Stress, depression and Parkinson's disease

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 79-86

  Hemmerle, Ann M ^a,b   Herman, James P ^a,b   Seroogy, Kim B ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Chronic variable stress; Dopamine; Glucocorticoids; HPA axis; Neurodegeneration; Non motor symptoms

Indexed keywords

DOPAMINE; GLUCOCORTICOID; GLUTAMIC ACID;

ACUTE STRESS; BEHAVIOR CHANGE; BRAIN REGION; CHRONIC STRESS; CLINICAL FEATURE; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; EXPERIMENTAL MODEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERMETHOD COMPARISON; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; CORPUS STRIATUM; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; NERVE DEGENERATION; PARKINSON DISEASE; STRESS, PSYCHOLOGICAL;

EID: 84856196201     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.09.035     Document Type: Review

References (156)

1. Aarsland D., Marsh L., Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov. Disord. 2009, 24:2175-2186.
2. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 1989, 52:1655-1658.
3. Adzic M., Djordjevic J., Djordjevic A., Niciforovic A., Demonacos C., Radojcic M., Krstic-Demonacos M. Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain. J. Endocrinol. 2009, 202:87-97.
4. Ahima R.S., Harlan R.E. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 1990, 39:579-604.
5. Ahmad A., Rasheed N., Banu N., Palit G. Alterations in monoamine levels and oxidative systems in frontal cortex, striatum, and hippocampus of the rat brain during chronic unpredictable stress. Stress 2010, 13:355-364.
6. Arranz B., Blennow K., Eriksson A., Mansson J.E., Marcusson J. Serotonergic, noradrenergic, and dopaminergic measures in suicide brains. Biol. Psychiatry 1997, 41:1000-1009.
7. Bachis A., Cruz M.I., Nosheny R.L., Mocchetti I. Chronic unpredictable stress promotes neuronal apoptosis in the cerebral cortex. Neurosci. Lett. 2008, 442:104-108.
8. Barone P., Lamb J., Ellis A., Clarke Z. Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease. Mov. Disord. 2007, 22:483-489.
9. Baydyuk M., Nguyen M.T., Xu B. Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration. Exp. Neurol. 2011, 228:118-125.
10. Bohnen N.I., Kaufer D.I., Hendrickson R., Constantine G.M., Mathis C.A., Moore R.Y. Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia. J. Neurol. Neurosurg. Psychiatry 2007, 78:641-643.
11. Boileau I., Warsh J.J., Guttman M., Saint-Cyr J.A., McCluskey T., Rusjan P., Houle S., Wilson A.A., Meyer J.H., Kish S.J. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Mov. Disord. 2008, 23:1776-1780.
12. Brown A.S., Gershon S. Dopamine and depression. J. Neural Transm. Gen. Sect. 1993, 91:75-109.
13. Brown R., Jahanshahi M. Depression in Parkinson's disease: a psychosocial viewpoint. Adv. Neurol. 1995, 65:61-84.
14. Brown J., Cooper-Kuhn C.M., Kempermann G., Van Praag H., Winkler J., Gage F.H., Kuhn H.G. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur. J. Neurosci. 2003, 17:2042-2046.
15. Cardoso E.F., Maia F.M., Fregni F., Myczkowski M.L., Melo L.M., Sato J.R., Marcolin M.A., Rigonatti S.P., Cruz A.C., Barbosa E.R., Amaro E. Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. NeuroImage 2009, 47:467-472.
16. Castro S.L., Zigmond M.J. Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra. Brain Res. 2001, 901:47-54.
17. Cerqueira J.J., Pego J.M., Taipa R., Bessa J.M., Almeida O.F., Sousa N. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J. Neurosci. 2005, 25:7792-7800.
18. Chan-Palay V., Asan E. Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J. Comp. Neurol. 1989, 287:357-372.
19. Chan-Palay V., Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J. Comp. Neurol. 1989, 287:373-392.
20. Charlett A., Dobbs R.J., Purkiss A.G., Wright D.J., Peterson D.W., Weller C., Dobbs S.M. Cortisol is higher in parkinsonism and associated with gait deficit. Acta Neurol. Scand. 1998, 97:77-85.
21. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol. 2009, 8:464-474.
22. Cummings J.L. Depression and Parkinson's disease: a review. Am. J. Psychiatry 1992, 149:443-454.
23. Dias-Ferreira E., Sousa J.C., Melo I., Morgado P., Mesquita A.R., Cerqueira J.J., Costa R.M., Sousa N. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009, 325:621-625.
24. Duman R.S. Pathophysiology of depression: the concept of synaptic plasticity. Eur. Psychiatry 2002, 17(Suppl. 3):306-310.
25. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromolecular Med. 2004, 5:11-25.
26. Duman R.S. Depression: a case of neuronal life and death?. Biol. Psychiatry 2004, 56:140-145.
27. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 2006, 59:1116-1127.
28. Duval F., Mokrani M.C., Monreal-Ortiz J.A., Fattah S., Champeval C., Schulz P., Macher J.P. Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology 2006, 31:876-888.
29. Finlay J.M., Zigmond M.J. The effects of stress on central dopaminergic neurons: possible clinical implications. Neurochem. Res. 1997, 22:1387-1394.
30. Forlenza M.J., Miller G.E. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom. Med. 2006, 68:1-7.
31. Fox S.H., Chuang R., Brotchie J.M. Serotonin and Parkinson's disease: on movement, mood, and madness. Mov. Disord. 2009, 24:1255-1266.
32. Frank-Cannon T.C., Alto L.T., McAlpine F.E., Tansey M.G. Does neuroinflammation fan the flame in neurodegenerative diseases?. Mol. Neurodegener. 2009, 4:47.
33. Fuchs E., Flügge G. Stress, glucocorticoids and structural plasticity of the hippocampus. Neurosci. Biobehav. Rev. 1998, 23:295-300.
34. Gibberd F.B., Simmonds J.P. Neurological disease in ex-Far-East prisoners of war. Lancet 1980, 2:135-137.
35. Giladi N., Treves T.A., Paleacu D., Shabtai H., Kandinov B., Simon E.S., Korczyn A.D. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J. Neural Transm. 2000, 107:59-71.
36. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 2002, 7:254-275.
37. Gold P.W., Goodwin F.K., Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress. N. Engl. J. Med. 1988, 319:413-420.
38. Gould E., Tanapat P. Stress and hippocampal neurogenesis. Biol. Psychiatry 1999, 46:1472-1479.
39. Gould E., Woolley C.S., Cameron H.A., Daniels D.C., McEwen B.S. Adrenal steroids regulate postnatal development of the rat dentate gyrus: II. Effects of glucocorticoids and mineralocorticoids on cell birth. J. Comp. Neurol. 1991, 313:486-493.
40. Gresch P.J., Sved A.F., Zigmond M.J., Finlay J.M. Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat. J. Neurochem. 1994, 63:575-583.
41. Grippo A.J., Francis J., Beltz T.G., Felder R.B., Johnson A.K. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol. Behav. 2005, 84:697-706.
42. Härfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., Wikström A.C., Okret S., Yu Z.Y., Goldstein M., Steinbusch H., Verhofstad A., Gustafsson J.-Å. Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:9779-9783.
43. Hemmerle A.M., Dickerson J.W., Packard B.A., Jones K.R., Dolgas C.M., Herman J.P., Seroogy K.B. Temporal effects of chronic variable stress on dopaminergic cell degeneration and motor deficits in a partial lesion model of Parkinson's disease. Soc. Neurosci. 2008, Abstr. #741.13.
44. Hemmerle A.M., Kyser T.L., Schmeltzer S.N., Lundgren K.H., Herman J.P., Seroogy K.B. Do glucocorticoids mediate chronic stress-induced exacerbation of neurodegeneration and behavioral dysfunction in experimental parkinsonism?. Soc. Neurosci. 2011, Abstr. Abstr. #883.06.
45. Herman J.P. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system. Cell. Mol. Neurobiol. 1993, 13:349-372.
46. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997, 20:78-84.
47. Herman J.P., Adams D., Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995, 61:180-190.
48. Hesse S., Meyer P.M., Strecker K., Barthel H., Wegner F., Oehlwein C., Isaias I.U., Schwarz J., Sabri O. Monoamine transporter availability in Parkinson's disease patients with or without depression. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:428-435.
49. Heuser I.J., Chase T.N., Mouradian M.M. The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease. Biol. Psychiatry 1991, 30:943-952.
50. Howells F.M., Russell V.A., Mabandla M.V., Kellaway L.A. Stress reduces the neuroprotective effect of exercise in a rat model for Parkinson's disease. Behav. Brain Res. 2005, 165:210-220.
51. Imperato A., Puglisi-Allegra S., Zocchi A., Scrocco M.G., Casolini P., Angelucci L. Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam. Eur. J. Pharmacol. 1990, 175:211-214.
52. Issa A.M., Rowe W., Gauthier S., Meaney M.J. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J. Neurosci. 1990, 10:3247-3254.
53. Kanner A.M. Is major depression a neurologic disorder with psychiatric symptoms?. Epilepsy Behav. 2004, 5:636-644.
54. Kathol R.G., Jaeckle R.S., Lopez J.F., Meller W.H. Pathophysiology of HPA axis abnormalities in patients with major depression: an update. Am. J. Psychiatry 1989, 146:311-317.
55. Katz R.J., Roth K.A., Carroll B.J. Acute and chronic stress effects on open field activity in the rat: implications for a model of depression. Neurosci. Biobehav. Rev. 1981, 5:247-251.
56. Keefe K.A., Stricker E.M., Zigmond M.J., Abercrombie E.D. Environmental stress increases extracellular dopamine in striatum of 6-hydroxydopamine-treated rats: in vivo microdialysis studies. Brain Res. 1990, 527:350-353.
57. Kendler K.S., Karkowski L.M., Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am. J. Psychiatry 1999, 156:837-841.
58. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 2003, 289:3095-3105.
59. Kibel A., Drenjancevic-Peric I. Impact of glucocorticoids and chronic stress on progression of Parkinson's disease. Med. Hypotheses 2008, 71:952-956.
60. Kim S.T., Choi J.H., Chang J.W., Kim S.W., Hwang O. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J. Neurochem. 2005, 95:89-98.
61. Kosten T.A., Galloway M.P., Duman R.S., Russell D.S., D'Sa C. Repeated unpredictable stress and antidepressants differentially regulate expression of the bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 2008, 33:1545-1558.
62. Kostić V.S., Agosta F., Petrović I., Galantucci S., Spica V., Jecmenica-Lukic M., Filippi M. Regional patterns of brain tissue loss associated with depression in Parkinson disease. Neurology 2010, 75:857-863.
63. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:744-759.
64. Kummer A., Cardoso F., Teixeira A.L. Suicidal ideation in Parkinson's disease. CNS Spectr. 2009, 14:431-436.
65. Kuopio A.M., Marttila R.J., Helenius H., Toivonen M., Rinne U.K. The quality of life in Parkinson's disease. Mov. Disord. 2000, 15:216-223.
66. Landfield P.W., Eldridge J.C. Increased affinity of type II corticosteroid binding in aged rat hippocampus. Exp. Neurol. 1989, 106:110-113.
67. Lavretsky H., Roybal D.J., Ballmaier M., Toga A.W., Kumar A. Antidepressant exposure may protect against decrement in frontal gray matter volumes in geriatric depression. J. Clin. Psychiatry 2005, 66:964-967.
68. Leentjens A.F. Depression in Parkinson's disease: conceptual issues and clinical challenges. J. Geriatr. Psychiatry Neurol. 2004, 17:120-126.
69. Leentjens A.F. The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review. Drugs 2011, 71:273-286.
70. Leentjens A.F., Van den Akker M., Metsemakers J.F., Lousberg R., Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov. Disord. 2003, 18:414-418.
71. Leentjens A.F., Vreeling F.W., Luijckx G.J., Verhey F.R. SSRIs in the treatment of depression in Parkinson's disease. Int. J. Geriatr. Psychiatry 2003, 18:552-554.
72. Lemke M.R. Depressive symptoms in Parkinson's disease. Eur. J. Neurol. 2008, 1(Suppl):21-25.
73. Li W., Liu J., Skidmore F., Liu Y., Tian J., Li K. White matter microstructure changes in the thalamus in Parkinson disease with depression: a diffusion tensor MR imaging study. AJNR Am. J. Neuroradiol. 2010, 31:1861-1866.
74. Lieberman A. Depression in Parkinson's disease - a review. Acta Neurol. Scand. 2006, 113:1-8.
75. Lucca G., Comim C.M., Valvassori S.S., Reus G.Z., Vuolo F., Petronilho F., Dal-Pizzol F., Gavioli E.C., Quevedo J. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem. Int. 2009, 54:358-362.
76. Lucca G., Comim C.M., Valvassori S.S., Réus G.Z., Vuolo F., Petronilho F., Gavioli E.C., Dal-Pizzol F., Quevedo J. Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. J. Psychiatr. Res. 2009, 43:864-869.
77. Mabandla M.V., Russell V.A. Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. Behav. Brain Res. 2010, 211:16-22.
78. Mabandla M.V., Kellaway L.A., Daniels W.M., Russell V.A. Effect of exercise on dopamine neuron survival in prenatally stressed rats. Metab. Brain Dis. 2009, 24:525-539.
79. Macht M., Brandstetter S., Ellgring H. Stress affects hedonic responses but not reaching-grasping in Parkinson's disease. Behav. Brain Res. 2007, 177:171-174.
80. Maes M., Yirmyia R., Noraberg J., Brene S., Hibbeln J., Perini G., Kubera M., Bob P., Lerer B., Maj M. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
81. Magariños A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995, 69:89-98.
82. Magariños A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience 1995, 69:83-88.
83. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 2000, 20:9104-9110.
84. Matthews K., Robbins T.W. Early experience as a determinant of adult behavioural responses to reward: the effects of repeated maternal separation in the rat. Neurosci. Biobehav. Rev. 2003, 27:45-55.
85. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., Schwalb J.M., Kennedy S.H. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
86. Mayeux R., Stern Y., Cote L., Williams J.B. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984, 34:642-646.
87. McDonald W.M., Richard I.H., DeLong M.R. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol. Psychiatry 2003, 54:363-375.
88. McGonagle K.A., Kessler R.C. Chronic stress, acute stress, and depressive symptoms. Am. J. Community Psychol. 1990, 18:681-706.
89. Menza M.A., Mark M.H. Parkinson's disease and depression: the relationship to disability and personality. J. Neuropsychiatry Clin. Neurosci. 1994, 6:165-169.
90. Metz G.A. Stress as a modulator of motor system function and pathology. Rev. Neurosci. 2007, 18:209-222.
91. Metz G.A., Jadavji N.M., Smith L.K. Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior. Eur. J. Neurosci. 2005, 22:1190-1200.
92. Meyer P.M., Strecker K., Kendziorra K., Becker G., Hesse S., Woelpl D., Hensel A., Patt M., Sorger D., Wegner F., Lobsien D., Barthel H., Brust P., Gertz H.J., Sabri O., Schwarz J. Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch. Gen. Psychiatry 2009, 66:866-877.
93. Mitra R., Sapolsky R.M. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc. Natl Acad. Sci. USA 2008, 105:5573-5578.
94. Mizoguchi K., Shoji H., Ikeda R., Tanaka Y., Tabira T. Persistent depressive state after chronic stress in rats is accompanied by HPA axis dysregulation and reduced prefrontal dopaminergic neurotransmission. Pharmacol. Biochem. Behav. 2008, 91:170-175.
95. Müller T., Welnic J., Muhlack S. Acute levodopa administration reduces cortisol release in patients with Parkinson's disease. J. Neural Transm. 2007, 114:347-350.
96. Murphy E.K., Spencer R.L., Sipe K.J., Herman J.P. Decrements in nuclear glucocorticoid receptor (GR) protein levels and DNA binding in aged rat hippocampus. Endocrinology 2002, 143:1362-1370.
97. Nagatsu T., Sawada M. Inflammatory process in Parkinson's disease: role for cytokines. Curr. Pharm. Des. 2005, 11:999-1016.
98. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., Kilts C.D., Loosen P.T., Vale W. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226:1342-1344.
99. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
100. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
101. Nilsson F.M., Kessing L.V., Bolwig T.G. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr. Scand. 2001, 104:380-386.
102. Pålhagen S.E., Carlsson M., Curman E., Walinder J., Granerus A.K. Depressive illness in Parkinson's disease - indication of a more advanced and widespread neurodegenerative process?. Acta Neurol. Scand. 2008, 117:295-304.
103. Pani L., Porcella A., Gessa G.L. The role of stress in the pathophysiology of the dopaminergic system. Mol. Psychiatry 2000, 5:14-21.
104. Papapetropoulos S., Ellul J., Argyriou A.A., Chroni E., Lekka N.P. The effect of depression on motor function and disease severity of Parkinson's disease. Clin. Neurol. Neurosurg. 2006, 108:465-469.
105. Papp M., Willner P., Muscat R. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacology (Berl) 1993, 110:159-164.
106. Patacchioli F.R., Monnazzi P., Scontrini A., Tremante E., Caridi I., Brunetti E., Buttarelli F.R., Pontieri F.E. Adrenal dysregulation in amyotrophic lateral sclerosis. J. Endocrinol. Invest. 2003, 26:RC23-RC25.
107. Pham K., Nacher J., Hof P.R., McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci. 2003, 17:879-886.
108. Pienaar I.S., Kellaway L.A., Russell V.A., Smith A.D., Stein D.J., Zigmond M.J., Daniels W.M. Maternal separation exaggerates the toxic effects of 6-hydroxydopamine in rats: implications for neurodegenerative disorders. Stress 2008, 11:448-456.
109. Qian L., Flood P.M., Hong J.S. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J. Neural Transm. 2010, 117:971-979.
110. Radley J.J., Sisti H.M., Hao J., Rocher A.B., McCall T., Hof P.R., McEwen B.S., Morrison J.H. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 2004, 125:1-6.
111. Rasheed N., Ahmad A., Pandey C.P., Chaturvedi R.K., Lohani M., Palit G. Differential response of central dopaminergic system in acute and chronic unpredictable stress models in rats. Neurochem. Res. 2010, 35:22-32.
112. Reijnders J.S., Scholtissen B., Weber W.E., Aalten P., Verhey F.R., Leentjens A.F. Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov. Disord. 2010, 25:2318-2325.
113. Remy P., Doder M., Lees A., Turjanski N., Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005, 128:1314-1322.
114. Richard I.H. Depression and apathy in Parkinson's disease. Curr. Neurol. Neurosci. Rep. 2007, 7:295-301.
115. Richard I.H., Kurlan R. A survey of antidepressant drug use in Parkinson's disease. Parkinson study group. Neurology 1997, 49:1168-1170.
116. Riedel O., Klotsche J., Spottke A., Deuschl G., Förstl H., Henn F., Heuser I., Oertel W., Reichmann H., Riederer P., Trenkwalder C., Dodel R., Wittchen H.U. Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease. J. Neurol. 2010, 257:1073-1082.
117. Ros-Bernal F., Hunot S., Herrero M.T., Parnadeau S., Corvol J.C., Lu L., Alvarez-Fischer D., Carrillo-de Sauvage M.A., Saurini F., Coussieu C., Kinugawa K., Prigent A., Höglinger G., Hamon M., Tronche F., Hirsch E.C., Vyas S. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc. Natl Acad. Sci. USA 2011, 108:6632-6637.
118. Salvadore G., Nugent A.C., Lemaitre H., Luckenbaugh D.A., Tinsley R., Cannon D.M., Neumeister A., Zarate C.A., Drevets W.C. Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. NeuroImage 2011, 54:2643-2651.
119. Sapolsky R.M. The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann. N. Y. Acad. Sci. 1994, 746:294-304.
120. Sapolsky R.M., Krey L.C., McEwen B.S. Corticosterone receptors decline in a site-specific manner in the aged rat brain. Brain Res. 1983, 289:235-240.
121. Sapolsky R.M., Krey L.C., McEwen B.S. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 1985, 5:1222-1227.
122. Sapolsky R.M., Packan D.R., Vale W.W. Glucocorticoid toxicity in the hippocampus: in vitro demonstration. Brain Res. 1988, 453:367-371.
123. Schaaf M.J., Hoetelmans R.W., de Kloet E.R., Vreugdenhil E. Corticosterone regulates expression of BDNF and trkB but not NT-3 and trkC mRNA in the rat hippocampus. J. Neurosci. Res. 1997, 48:334-341.
124. Schaaf M.J., de Jong J., de Kloet E.R., Vreugdenhil E. Downregulation of BDNF mRNA and protein in the rat hippocampus by corticosterone. Brain Res. 1998, 813:112-120.
125. Schrag A. Quality of life and depression in Parkinson's disease. J. Neurol. Sci. 2006, 248:151-157.
126. Schrag A., Hovris A., Morley D., Quinn N., Jahanshahi M. Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov. Disord. 2003, 18:1250-1256.
127. Serra-Mestres J., Ring H.A. Evidence supporting a cognitive model of depression in Parkinson's disease. J. Nerv. Ment. Dis. 2002, 190:407-410.
128. Sheline Y.I. Neuroimaging studies of mood disorder effects on the brain. Biol. Psychiatry 2003, 54:338-352.
129. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:3908-3913.
130. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 1995, 15:1768-1777.
131. Smith A.D., Castro S.L., Zigmond M.J. Stress-induced Parkinson's disease: a working hypothesis. Physiol. Behav. 2002, 77:527-531.
132. Smith L.K., Jadavji N.M., Colwell K.L., Katrina Perehudoff S., Metz G.A. Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease. Eur. J. Neurosci. 2008, 27:2133-2146.
133. Snyder A.M., Stricker E.M., Zigmond M.J. Stress-induced neurological impairments in an animal model of parkinsonism. Ann. Neurol. 1985, 18:544-551.
134. Song L., Che W., Min-Wei W., Murakami Y., Matsumoto K. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacol. Biochem. Behav. 2006, 83:186-193.
135. Steffens D.C., Fisher G.G., Langa K.M., Potter G.G., Plassman B.L. Prevalence of depression among older Americans: the aging, demographics and memory study. Int. Psychogeriatr. 2009, 21:879-888.
136. Sun X.L., Liu Y., Dai T., Ding J.H., Hu G. Uncoupling protein 2 knockout exacerbates depression-like behaviors in mice via enhancing inflammatory response. Neuroscience 2011, 192:507-514.
137. Suzuki K., Okada K., Wakuda T., Shinmura C., Kameno Y., Iwata K., Takahashi T., Suda S., Matsuzaki H., Iwata Y., Hashimoto K., Mori N. Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine. PLoS One 2010, 5:e9260.
138. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 2005, 4:141-194.
139. Tagliari B., dos Santos T.M., Cunha A.A., Lima D.D., Delwing D., Sitta A., Vargas C.R., Dalmaz C., Wyse A.T. Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats. J. Neural Transm. 2010, 117:1067-1076.
140. Tang Y., Wang F., Xie G., Liu J., Li L., Su L., Liu Y., Hu X., He Z., Blumberg H.P. Reduced ventral anterior cingulate and amygdala volumes in medication-naïve females with major depressive disorder: a voxel-based morphometric magnetic resonance imaging study. Psychiatry Res. 2007, 156:83-86.
141. Ulrich-Lai Y.M., Herman J.P. Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 2009, 10:397-409.
142. Van Craenenbroeck K., De Bosscher K., Vanden Berghe W., Vanhoenacker P., Haegeman G. Role of glucocorticoids in dopamine-related neuropsychiatric disorders. Mol. Cell. Endocrinol. 2005, 245:10-22.
143. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 2002, 22:6810-6818.
144. Wang S.S., Yan X.B., Hofman M.A., Swaab D.F., Zhou J.N. Increased expression level of corticotropin-releasing hormone in the amygdala and in the hypothalamus in rats exposed to chronic unpredictable mild stress. Neurosci. Bull. 2010, 26:297-303.
145. Weintraub D., Newberg A.B., Cary M.S., Siderowf A.D., Moberg P.J., Kleiner-Fisman G., Duda J.E., Stern M.B., Mozley D., Katz I.R. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J. Nucl. Med. 2005, 46:227-232.
146. Weintraub D., Comella C.L., Horn S. Parkinson's disease - part 1: pathophysiology, symptoms, burden, diagnosis, and assessment. Am. J. Manage. Care 2008, 14:S40-S48.
147. Weintraub D., Comella C.L., Horn S. Parkinson's disease - part 3: neuropsychiatric symptoms. Am. J. Manage. Care 2008, 14:S59-S69.
148. Wellman C.L. Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J. Neurobiol. 2001, 49:245-253.
149. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005, 52:90-110.
150. Wise R.A. Roles for nigrostriatal - not just mesocorticolimbic - dopamine in reward and addiction. Trends Neurosci. 2009, 32:517-524.
151. Wu S.Y., Wang T.F., Yu L., Jen C.J., Chuang J.I., Wu F.S., Wu C.W., Kuo Y.M. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway. Brain Behav. Immun. 2011, 25:135-146.
152. Yamamoto M. Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background. J. Neurol. 2001, 248(Suppl. 3):III5-III11.
153. Yang D., Liu X., Zhang R., Cheng K., Mu J., Fang L., Xie P. Increased apoptosis and different regulation of pro-apoptosis protein bax and anti-apoptosisprotein bcl-2 in the olfactory bulb of a rat model of depression. Neurosci. Lett. 2011, 504:18-22.
154. Yehuda R., Yang R.K., Buchsbaum M.S., Golier J.A. Alterations in cortisol negative feedback inhibition as examined using the ACTH response to cortisol administration in PTSD. Psychoneuroendocrinology 2006, 31:447-451.
155. You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., Zuo R., Wu Y. Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: Involvement in depression. Behav. Brain Res. 2011, 225:135-141.
156. Ziegler D.R., Cass W.A., Herman J.P. Excitatory influence of the locus coeruleus in hypothalamic-pituitry-adrenocortical axis responses to stress. J. Neuroendocrinol. 1999, 11:361-369.